河北医科大学学报 ›› 2025, Vol. 46 ›› Issue (8): 939-946.doi: 10.3969/j.issn.1007-3205.2025.08.012

• • 上一篇    下一篇

白藜芦醇自微乳的吸收及安全性研究

  

  1. 1.河北化工医药职业技术学院药学与健康管理系药学教研部,河北 石家庄 050026;
    2.河北医科大学药学院药剂教研室,河北 石家庄 050017

  • 出版日期:2025-08-25 发布日期:2025-08-29
  • 作者简介:曹璐(1988-),女,河北石家庄人,河北化工医药职业技术学院副教授,医学硕士,从事药物新剂型研究。

  • 基金资助:
    河北省教育厅科学技术研究资助项目(QN2021048)

Study on absorption and safety of resveratrol self-microemulsion

  1. 1.Teaching and Research Section of Pharmacy, Department of Pharmacy and Health Management, 
    Hebei Chemical and Pharmaceutical College, Shijiazhuang 050026, China; 2.Department of 
    Pharmaceutics, School of Pharmacy, Hebei Medical University, 
    Shijiazhuang 050017, China

  • Online:2025-08-25 Published:2025-08-29

摘要: 目的 考察白藜芦醇自微乳在大鼠体内的吸收情况和安全性。
方法 采用伪三元相图筛选并确定白藜芦醇自微乳最佳处方,并从粒径、形态、溶出度、稳定性方面评价自微乳质量特征,采用在体肠吸收试验考察白藜芦醇肠吸收情况,通过药代动力学试验考察自微乳口服生物利用度,并采用小鼠急性经口毒性试验评价自微乳的安全性。
结果 白藜芦醇自微乳最佳处方是三乙酸甘油酯22 g、聚氧乙烯蓖麻油27 g、聚氧乙烯氢化蓖麻油13.5 g、异丙醇37.8 g、白藜芦醇3.5 g,且粒径大小均匀(14.528±0.314) nm、稳定性良好。自微乳吸收速率常数和表观分布系数分别是混悬液的(2.131±0.576)倍、(2.382±0.688)倍,自微乳的血药峰时间和平均滞留时间、峰浓度和药时曲线下面积分别是混悬液的(3.272±0.403)倍、(2.531±0.569)倍、(3.588±0.454)倍、(10.985±2.997)倍。混悬液组、自微乳辅料组和自微乳组小鼠均未出现毒性反应和明显体重变化(P>0.05)。
结论 自微乳能够有效改善白藜芦醇的稳定性,显著提高了白藜芦醇的肠吸收和口服生物利用度,安全性良好,为拓展白藜芦醇的临床应用提供了试验依据。


关键词: 白藜芦醇, 药代动力学, 自微乳

Abstract: Objective To investigate the absorption and safety of resveratrol  self-microemulsion in rats. 
Methods The optimal formula for resveratrol self-microemulsion was chosen and determined using a pseudo-ternary phase diagram. The quality characteristics of the self-microemulsion were evaluated in terms of particle size, morphology, dissolution, and stability. The intestinal absorption of resveratrol was investigated through in vivo intestinal absorption tests, and the oral bioavailability of the self-microemulsion was assessed using pharmacokinetic tests. The safety of self-microemulsion was evaluated through an acute oral toxicity test in mice. 
Results The optimal formula for the resveratrol self-microemulsion included 22 g triacetate, 27 g polyoxyethylene castor oil, 13.5 g polyoxyethylene hydrogenated castor oil, 37.8 g isopropyl alcohol, and 3.5 g resveratrol. This mixture had a uniform particle size (14.528±0.314) nm and good stability. Compared with the suspension phase, the absorption rate constant (Ka) and apparent distribution coefficient (Papp) of the self-microemulsion were (2.131±0.576) times and (2.382±0.688) times respectively,  the time to reach peak blood concentration and mean residence time were (3.272±0.403) times and (2.531±0.569) times respectively, and both the peak concentration and the area under the curve were (3.588±0.454) times and (10.985±2.997) times respectively. No toxic reactions or obvious weight changes were observed in the suspension group, microemulsion adjuvant group, or self-microemulsion group (P>0.05). 
Conclusion The self-microemulsion effectively improves the stability of resveratrol, significantly enhances its intestinal absorption and oral bioavailability, and has good safety, providing an experimental basis for expanding the clinical application of resveratrol. 


Key words: resveratrol, pharmacokinetics, self-microemulsion